PT3714877T - Método e composição para tratamento de hipertensão ocular e glaucoma - Google Patents
Método e composição para tratamento de hipertensão ocular e glaucomaInfo
- Publication number
- PT3714877T PT3714877T PT201646023T PT20164602T PT3714877T PT 3714877 T PT3714877 T PT 3714877T PT 201646023 T PT201646023 T PT 201646023T PT 20164602 T PT20164602 T PT 20164602T PT 3714877 T PT3714877 T PT 3714877T
- Authority
- PT
- Portugal
- Prior art keywords
- glaucoma
- composition
- ocular hypertension
- treating ocular
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08397513A EP2127638A1 (en) | 2008-05-30 | 2008-05-30 | Method and composition for treating ocular hypertension and glaucoma |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3714877T true PT3714877T (pt) | 2022-03-10 |
Family
ID=39940592
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT170004402T PT3205334T (pt) | 2008-05-30 | 2009-05-28 | Método e composição para tratamento de hipertensão ocular e glaucoma |
PT140018623T PT2772249T (pt) | 2008-05-30 | 2009-05-28 | Método e composição para tratamento de hipertensão ocular e glaucoma |
PT97548648T PT2306977E (pt) | 2008-05-30 | 2009-05-28 | Método e composição para tratamento de hipertensão ocular e glaucoma |
PT201646023T PT3714877T (pt) | 2008-05-30 | 2009-05-28 | Método e composição para tratamento de hipertensão ocular e glaucoma |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT170004402T PT3205334T (pt) | 2008-05-30 | 2009-05-28 | Método e composição para tratamento de hipertensão ocular e glaucoma |
PT140018623T PT2772249T (pt) | 2008-05-30 | 2009-05-28 | Método e composição para tratamento de hipertensão ocular e glaucoma |
PT97548648T PT2306977E (pt) | 2008-05-30 | 2009-05-28 | Método e composição para tratamento de hipertensão ocular e glaucoma |
Country Status (27)
Country | Link |
---|---|
US (3) | US9999593B2 (pt) |
EP (7) | EP2127638A1 (pt) |
JP (9) | JP2011521943A (pt) |
KR (5) | KR101650006B1 (pt) |
CN (1) | CN102083413B (pt) |
AR (2) | AR071937A1 (pt) |
AU (1) | AU2009252210C1 (pt) |
BR (1) | BRPI0913109B8 (pt) |
CA (2) | CA2724194C (pt) |
CY (2) | CY1115565T1 (pt) |
DK (4) | DK2306977T3 (pt) |
EA (1) | EA023661B1 (pt) |
ES (5) | ES2808050T3 (pt) |
GE (1) | GEP20156220B (pt) |
HR (4) | HRP20220361T1 (pt) |
HU (3) | HUE033103T2 (pt) |
JO (1) | JO3039B1 (pt) |
LT (3) | LT2772249T (pt) |
MX (1) | MX2010012987A (pt) |
MY (1) | MY159463A (pt) |
PL (4) | PL2772249T3 (pt) |
PT (4) | PT3205334T (pt) |
SG (1) | SG191628A1 (pt) |
SI (4) | SI3714877T1 (pt) |
TW (1) | TWI432202B (pt) |
UA (1) | UA102257C2 (pt) |
WO (1) | WO2009145356A1 (pt) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI544927B (zh) | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
EP2127638A1 (en) * | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
EP2228058A1 (en) | 2009-03-04 | 2010-09-15 | Novagali Pharma S.A. | Anionic oil-in-water emulsion containing prostaglandins and uses thereof |
EP2389939A1 (en) * | 2010-05-28 | 2011-11-30 | Novagali Pharma S.A. | Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions |
US20110136872A1 (en) * | 2009-12-09 | 2011-06-09 | Burk Robert M | Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof |
JP5681472B2 (ja) * | 2009-12-28 | 2015-03-11 | ロート製薬株式会社 | 眼科用組成物 |
FR2961694B1 (fr) * | 2010-06-29 | 2013-01-25 | Thea Lab | Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur |
AU2011282681B2 (en) * | 2010-07-29 | 2015-07-30 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
US9061034B2 (en) | 2010-07-29 | 2015-06-23 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
EP2598117A2 (en) * | 2010-07-29 | 2013-06-05 | Allergan, Inc. | Preservative free bimatoprost solutions |
WO2012021107A2 (en) | 2010-08-12 | 2012-02-16 | Nanyang Technological University | A liposomal formulation for ocular drug delivery |
EP2618810B1 (en) | 2010-09-21 | 2016-11-23 | S & V Technologies GmbH | Cosmetic composition |
EP2452669A1 (en) * | 2010-10-29 | 2012-05-16 | Omnivision GmbH | Ophthalmic composition |
WO2012141334A1 (en) * | 2011-04-12 | 2012-10-18 | R-Tech Ueno, Ltd. | Aqueous ophthalmic composition |
CN102716074B (zh) * | 2012-06-28 | 2013-10-16 | 武汉武药科技有限公司 | 一种贝美前列素滴眼剂及其制备方法 |
FI2887923T3 (fi) * | 2012-08-24 | 2023-06-30 | Sun Pharmaceutical Ind Ltd | Polyoksylilipidin tai polyoksylirasvahapon oftalminen formulaatio ja silmätilojen hoito |
US9956195B2 (en) | 2014-01-07 | 2018-05-01 | Nanyang Technological University | Stable liposomal formulations for ocular drug delivery |
US9913849B2 (en) | 2014-01-10 | 2018-03-13 | Manistee Partners Llc | Treatment of migraines |
CN104766952B (zh) * | 2015-04-21 | 2017-01-25 | 武汉凯迪工程技术研究总院有限公司 | 利用生物质气化炉滤渣制备锂离子电池负极材料的方法 |
EP3103439B1 (en) | 2015-06-09 | 2019-08-07 | MEDproject Pharma-Entwicklungs- und Vertriebsgesellschaft mbH | Drippable ophthalmic bimatoprost gel |
US10105371B2 (en) * | 2015-10-09 | 2018-10-23 | Tamara Vrabec | Use of medications with neuroprotective properties to prevent or reduce the risk of ischemia-reperfusion injury in a subject |
CA3004587A1 (en) * | 2015-11-06 | 2017-05-11 | Accuitis Pharmaceuticals, Inc. | Use of proteasome inhibitors to treat ocular disorders |
BR112018067946A8 (pt) | 2016-02-29 | 2022-11-08 | Sun Pharma Global Fze | Formulações tópicas contendo ciclosporina e usos das mesmas |
GR1009040B (el) | 2016-04-19 | 2017-05-19 | Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων | Φαρμακευτικο οφθαλμικο σκευασμα ελευθερο συντηρητικου |
WO2018033854A1 (en) * | 2016-08-15 | 2018-02-22 | Santen Pharmaceutical Co., Ltd. | Ophthalmic composition and a method for treating ocular hypertension and glaucoma |
KR101770324B1 (ko) * | 2016-11-09 | 2017-08-22 | 주식회사태준제약 | 안압 강하용 점안 조성물 |
JP2020059652A (ja) * | 2016-12-26 | 2020-04-16 | 参天製薬株式会社 | タフルプロストとクエン酸エステルとを含有するデポ剤 |
ES2972844T3 (es) * | 2017-03-27 | 2024-06-17 | Alcon Inc | Preparación farmacéutica |
US20180318319A1 (en) * | 2017-05-04 | 2018-11-08 | Ocular Science, Inc. | Compositions and Methods for Treating Eyes and Methods of Preparation |
EP3643297A4 (en) | 2017-06-22 | 2021-03-17 | Yonsung Fine Chemical Co., Ltd. | OPHTHALMIC COMPOSITION FOR GLUCOMA TREATMENT |
CN111479568A (zh) * | 2017-12-21 | 2020-07-31 | 参天制药株式会社 | 司培前列素与Rho激酶抑制剂的组合药物 |
WO2020013717A1 (en) | 2018-07-09 | 2020-01-16 | Warszawskie Zaklady Farmaceutyczne Polfa Sa | Ophthalmic dispensing device |
CN111632025A (zh) * | 2020-03-04 | 2020-09-08 | 吉林大学第一医院 | 一种贝美前列素眼用温度敏感型原位凝胶及其制备方法与应用 |
CN111840225B (zh) * | 2020-08-12 | 2021-09-14 | 陈丽娜 | 一种用于治疗青光眼的滴眼剂及其制备方法 |
RU2761625C2 (ru) * | 2021-02-11 | 2021-12-13 | Общество с ограниченной ответственностью "Гротекс" (ООО "Гротекс") | Фармацевтическая композиция тафлупроста |
WO2023182480A1 (ja) * | 2022-03-25 | 2023-09-28 | 株式会社坪田ラボ | 水性組成物 |
WO2023241652A1 (zh) * | 2022-06-16 | 2023-12-21 | 广州润尔眼科生物科技有限公司 | 一种药物组合物及其制备方法和应用 |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4778815A (en) * | 1987-03-18 | 1988-10-18 | Ciba-Geigy Corporation | Method of inhibiting cataracts by topical application of a 2-substituted 1,2-benzisoselenazol-3(2H)-one |
EP0286903B2 (en) | 1987-04-03 | 2000-03-29 | The Trustees Of Columbia University In The City Of New York | Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure |
US5409125A (en) | 1989-12-11 | 1995-04-25 | Aktiebolaget Astra | Unit dose container |
DE4027320C2 (de) | 1990-08-29 | 1993-09-30 | Ursapharm Arzneimittel Gmbh | Fluid-Abgabeeinrichtung für keimfreies Fluid |
JPH0655640A (ja) | 1992-08-04 | 1994-03-01 | Aavan Internatl:Kk | 洗面台カウンター及びその製造方法 |
JPH06107547A (ja) | 1992-10-01 | 1994-04-19 | Aarutetsuku Ueno:Kk | 眼科用組成物 |
AU665287B2 (en) | 1992-12-21 | 1995-12-21 | Alcon Laboratories, Inc. | Prostaglandin combinations in glaucoma therapy |
JP2510066Y2 (ja) | 1993-01-20 | 1996-09-11 | 東洋製罐株式会社 | 加熱殺菌可能な液体医薬容器 |
US5807892A (en) | 1994-09-30 | 1998-09-15 | Alcon Laboratories, Inc. | Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension |
US5631287A (en) | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
AU704938B2 (en) * | 1995-11-17 | 1999-05-06 | Alcon Laboratories, Inc. | Combination therapy for treating glaucoma |
DE69714274T3 (de) | 1996-09-17 | 2006-06-01 | Asahi Glass Co., Ltd. | Fluorierte prostaglandinderivate und medikamente |
WO1998025829A1 (en) | 1996-12-09 | 1998-06-18 | Bausch & Lomb Incorporated | Single-use flexible container |
JP3480549B2 (ja) | 1996-12-26 | 2003-12-22 | 参天製薬株式会社 | ジフルオロプロスタグランジン誘導体およびその用途 |
AR002194A1 (es) | 1997-03-17 | 1998-01-07 | Sanchez Reynaldo Alemany | Instrumento computarizado para el analisis del movimiento. |
EP0979652B1 (en) | 1997-10-13 | 2006-05-24 | R-Tech Ueno, Ltd. | Remedial composition for intraocular hypertension or glaucoma |
US6066671A (en) | 1997-12-19 | 2000-05-23 | Alcon Laboratories, Inc. | Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides |
GB2337740B (en) | 1998-05-26 | 2000-11-15 | Spreckelsen Mcgeough Ltd | Fluid packaging |
WO2000003736A1 (en) | 1998-07-14 | 2000-01-27 | Alcon Laboratories, Inc. | Prostaglandin product |
US6235781B1 (en) | 1998-07-14 | 2001-05-22 | Alcon Laboratories, Inc. | Prostaglandin product |
JP2003517441A (ja) | 1998-09-25 | 2003-05-27 | アルコン ラボラトリーズ, インコーポレイテッド | 徐放性で快適な眼疾病用組成物および眼疾病の治療方法 |
US6096783A (en) | 1998-12-15 | 2000-08-01 | Alcon Laboratories, Inc. | Cyclobutane prostaglandin analogues as ocular hypotensive agents |
AU2183900A (en) | 1998-12-24 | 2000-07-31 | Alcon Laboratories, Inc. | Ep4 receptor agonists for treatment of dry eye |
PL350924A1 (en) | 1999-04-06 | 2003-02-10 | Sepracor Inc | Derivatives of venlafaxine and methods of preparing and using the same |
AU2001264261A1 (en) | 2000-06-19 | 2002-01-02 | Santen Pharmaceutical Co. Ltd. | Aseptics |
JP3876355B2 (ja) * | 2000-09-13 | 2007-01-31 | 参天製薬株式会社 | 点眼液 |
DK1321144T3 (da) | 2000-09-13 | 2011-03-07 | Santen Pharmaceutical Co Ltd | Øjendråber |
TW586946B (en) | 2000-12-22 | 2004-05-11 | Novartis Ag | Process to improve stability |
AU2003248070A1 (en) | 2002-07-16 | 2004-02-02 | Hanshin Yoki Co., Ltd. | Chemical container and method of manufacturing the container |
KR101253941B1 (ko) | 2002-09-09 | 2013-04-16 | 산텐 세이야꾸 가부시키가이샤 | 라타노프로스트를 유효 성분으로 하는 투명한 점안액 |
US7074827B2 (en) * | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
EP1666043B1 (en) | 2003-07-31 | 2009-12-02 | Santen Pharmaceutical Co., Ltd. | Product containing prostaglandin |
US20050287325A1 (en) | 2004-06-25 | 2005-12-29 | Pharmacia & Upjohn Company | Pharmaceutical containers with low adsorption/absorption of active ingredients, and a method of testing materials for adsorption/absorption of active ingredients |
ATE412400T1 (de) | 2004-11-09 | 2008-11-15 | Novagali Pharma Sa | Öl-in-wasser-emulsion mit niedriger konzentration des kationischen mittels und positivem zetapotential |
WO2007042262A2 (en) | 2005-10-10 | 2007-04-19 | Novagali Pharma Sa | Ophthalmic emulsions containing prostaglandins |
WO2006058139A2 (en) | 2004-11-24 | 2006-06-01 | Holopack International Corp. | Dispensing container with flow control system |
CN102526064A (zh) * | 2004-12-09 | 2012-07-04 | 参天制药株式会社 | 含有分子内具有氟原子的***素的制品 |
DK1829545T3 (da) | 2004-12-24 | 2012-07-23 | Santen Pharmaceutical Co Ltd | Produkter indeholdende prostaglandin-F2alfa-derivat |
GB0501192D0 (en) * | 2005-01-20 | 2005-03-02 | Resolution Chemicals Ltd | Stable prostaglandin-containing compositions |
WO2007007832A1 (ja) | 2005-07-13 | 2007-01-18 | Santen Pharmaceutical Co., Ltd. | 眼科用防腐組成物 |
US8030349B2 (en) | 2005-08-02 | 2011-10-04 | Santen Pharmaceutical Co., Ltd. | Method for prevention of degradation of thermally unstable medicament |
FI126233B (sv) | 2006-02-23 | 2016-08-31 | Oy Kwh Mirka Ab | Oscillerande slipmaskin |
FR2918891B1 (fr) | 2007-07-20 | 2009-09-25 | Thea Sa Lab | Solution ophtalmique a base de prostaglandines sans conservateur |
KR100927617B1 (ko) | 2007-11-26 | 2009-11-23 | 한국표준과학연구원 | 열분해 탄소 성분의 나노 크기를 가지는 바이오 센서의감지부를 제작하는 방법 |
EP2127638A1 (en) | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
-
2008
- 2008-05-30 EP EP08397513A patent/EP2127638A1/en not_active Withdrawn
-
2009
- 2009-05-19 TW TW098116503A patent/TWI432202B/zh active
- 2009-05-27 JO JOP/2009/0192A patent/JO3039B1/ar active
- 2009-05-28 SG SG2013041751A patent/SG191628A1/en unknown
- 2009-05-28 PL PL14001862T patent/PL2772249T3/pl unknown
- 2009-05-28 PL PL20164602T patent/PL3714877T3/pl unknown
- 2009-05-28 PT PT170004402T patent/PT3205334T/pt unknown
- 2009-05-28 UA UAA201015619A patent/UA102257C2/uk unknown
- 2009-05-28 MY MYPI2010005463A patent/MY159463A/en unknown
- 2009-05-28 SI SI200932159T patent/SI3714877T1/sl unknown
- 2009-05-28 ES ES17000440T patent/ES2808050T3/es active Active
- 2009-05-28 PL PL17000440T patent/PL3205334T3/pl unknown
- 2009-05-28 HU HUE14001862A patent/HUE033103T2/en unknown
- 2009-05-28 EP EP14001862.3A patent/EP2772249B1/en not_active Revoked
- 2009-05-28 HU HUE17000440A patent/HUE049923T2/hu unknown
- 2009-05-28 AR ARP090101912A patent/AR071937A1/es not_active Application Discontinuation
- 2009-05-28 HR HRP20220361TT patent/HRP20220361T1/hr unknown
- 2009-05-28 EP EP17000440.2A patent/EP3205334B1/en active Active
- 2009-05-28 SI SI200932073T patent/SI3205334T1/sl unknown
- 2009-05-28 ES ES20164602T patent/ES2907982T3/es active Active
- 2009-05-28 KR KR1020107029072A patent/KR101650006B1/ko active IP Right Grant
- 2009-05-28 EA EA201071413A patent/EA023661B1/ru unknown
- 2009-05-28 AU AU2009252210A patent/AU2009252210C1/en active Active
- 2009-05-28 EP EP21217057.5A patent/EP4035656B1/en active Active
- 2009-05-28 PL PL09754864T patent/PL2306977T3/pl unknown
- 2009-05-28 LT LTEP14001862.3T patent/LT2772249T/lt unknown
- 2009-05-28 ES ES14001862.3T patent/ES2627837T3/es active Active
- 2009-05-28 CA CA2724194A patent/CA2724194C/en active Active
- 2009-05-28 JP JP2011511256A patent/JP2011521943A/ja active Pending
- 2009-05-28 KR KR1020197016340A patent/KR102114401B1/ko active IP Right Grant
- 2009-05-28 LT LTEP17000440.2T patent/LT3205334T/lt unknown
- 2009-05-28 EP EP20164602.3A patent/EP3714877B1/en active Active
- 2009-05-28 SI SI200931050T patent/SI2306977T1/sl unknown
- 2009-05-28 DK DK09754864.8T patent/DK2306977T3/da active
- 2009-05-28 ES ES09754864.8T patent/ES2495316T3/es active Active
- 2009-05-28 DK DK20164602.3T patent/DK3714877T3/da active
- 2009-05-28 LT LTEP20164602.3T patent/LT3714877T/lt unknown
- 2009-05-28 PT PT140018623T patent/PT2772249T/pt unknown
- 2009-05-28 ES ES21217057T patent/ES2968837T3/es active Active
- 2009-05-28 SI SI200931694T patent/SI2772249T1/sl unknown
- 2009-05-28 EP EP09754864.8A patent/EP2306977B1/en active Active
- 2009-05-28 KR KR1020187001130A patent/KR101988642B1/ko active IP Right Grant
- 2009-05-28 BR BRPI0913109A patent/BRPI0913109B8/pt active IP Right Grant
- 2009-05-28 EP EP23202597.3A patent/EP4289446A3/en active Pending
- 2009-05-28 DK DK14001862.3T patent/DK2772249T3/en active
- 2009-05-28 CN CN2009801197245A patent/CN102083413B/zh active Active
- 2009-05-28 PT PT97548648T patent/PT2306977E/pt unknown
- 2009-05-28 GE GEAP200912045A patent/GEP20156220B/en unknown
- 2009-05-28 KR KR1020167022210A patent/KR101820816B1/ko active IP Right Grant
- 2009-05-28 DK DK17000440.2T patent/DK3205334T3/da active
- 2009-05-28 PT PT201646023T patent/PT3714877T/pt unknown
- 2009-05-28 MX MX2010012987A patent/MX2010012987A/es active IP Right Grant
- 2009-05-28 HU HUE20164602A patent/HUE058079T2/hu unknown
- 2009-05-28 WO PCT/JP2009/060211 patent/WO2009145356A1/en active Application Filing
- 2009-05-28 US US12/995,351 patent/US9999593B2/en active Active
- 2009-05-28 CA CA2965185A patent/CA2965185A1/en not_active Abandoned
- 2009-05-28 KR KR1020207014211A patent/KR102246598B1/ko active IP Right Grant
-
2014
- 2014-04-22 JP JP2014088256A patent/JP2014133765A/ja active Pending
- 2014-09-18 CY CY20141100763T patent/CY1115565T1/el unknown
- 2014-10-14 HR HRP20140979AT patent/HRP20140979T1/hr unknown
-
2015
- 2015-12-07 JP JP2015238594A patent/JP6148317B2/ja active Active
-
2017
- 2017-05-18 JP JP2017098843A patent/JP6356868B2/ja active Active
- 2017-05-23 HR HRP20170769TT patent/HRP20170769T1/hr unknown
- 2017-06-27 CY CY20171100675T patent/CY1120351T1/el unknown
-
2018
- 2018-06-14 JP JP2018113647A patent/JP6649992B2/ja active Active
- 2018-06-18 US US16/010,739 patent/US10864159B2/en active Active
- 2018-11-01 AR ARP180103181A patent/AR120961A2/es not_active Application Discontinuation
-
2020
- 2020-01-17 JP JP2020005799A patent/JP6889789B2/ja active Active
- 2020-06-24 HR HRP20200998TT patent/HRP20200998T1/hr unknown
- 2020-11-11 US US17/094,986 patent/US20210059931A1/en not_active Abandoned
-
2021
- 2021-05-21 JP JP2021085839A patent/JP7265584B2/ja active Active
-
2023
- 2023-04-14 JP JP2023066348A patent/JP7520285B2/ja active Active
-
2024
- 2024-04-12 JP JP2024064531A patent/JP2024079852A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUE049923T2 (hu) | Eljárás és készítmény magas szemnyomás és zöldhályog kezelésére | |
HK1247821A1 (zh) | 用於預防或治療眼科病症的方法和組合物 | |
EP2083862A4 (en) | COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES AND DISORDERS | |
LT2374472T (lt) | Kompozicijos ir būdai oftalmologinių sutrikimų gydymui | |
IL186598A0 (en) | Composition and method for the treatment or prevention of glaucoma and ocular hypertension | |
HK1183693A1 (en) | Methods for treating eye disorders | |
IL202015A0 (en) | Methods and compositions for treating skin conditions | |
IL209948A0 (en) | Method of eye treatment for prevention of presbyopia and glaucoma, and means for carrying out said treatment | |
EP2344155A4 (en) | COMPOSITION AND METHOD FOR TREATING A DRY EYE | |
EP2147975A4 (en) | METHOD FOR DETERMINING THE RISK OF APPEARANCE OF GLAUCOMA | |
IL210097A0 (en) | Compositions and methods for treating unfluenza | |
IL207397A0 (en) | Difluorobiphenylamide derivtives for the treatment of ocular hypertension | |
HK1149545A1 (en) | Compositions and methods for treating ophthalmic diseases | |
EP2120994A4 (en) | METHOD AND COMPOSITIONS FOR TREATING HYPOGLYKEMIC CONDITIONS | |
GB0718918D0 (en) | Compositions and methods for treating skin conditions | |
EP2032130A4 (en) | OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF EYE HIGH PRESSURE | |
IL209947A0 (en) | Compositions and methods for treating corneal inflammation | |
EP2427052A4 (en) | METHODS AND COMPOSITIONS FOR USE IN THE TREATMENT OF OPHTHALMIC DISORDERS | |
AU2013207600A1 (en) | Methods and apparatus for treating glaucoma | |
IL197323A0 (en) | Novel method and compositions for prevention or treatment of glaucoma and ocular hypertension |